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Abstract
Background: While the Osteoporosis Canada 2002 Canadian guidelines provided evidence based strategies in
preventing, diagnosing, and managing this condition, publication and distribution of guidelines have not, in and of
themselves, been shown to alter physicians clinical approaches. We hypothesize that primary care physicians
enrolled in the Quality Circle project would change their patient management of osteoporosis in terms of
awareness of osteoporosis risk factors and bone mineral density testing in accordance with the guidelines.
Methods:  The project consisted of five Quality Circle phases that included: 1) Training & Baseline Data
Collection, 2) First Educational Intervention & First Follow-Up Data Collection 3) First Strategy Implementation
Session, 4) Final Educational Intervention & Final Follow-up Data Collection, and 5) Final Strategy Implementation
Session. A total of 340 circle members formed 34 quality circles and participated in the study. The generalized
estimating equations approach was used to model physician awareness of risk factors for osteoporosis and
appropriate utilization of bone mineral density testing pre and post educational intervention (first year of the
study). Odds ratios (OR) and 95% confidence intervals (95% CI) were calculated.
Results: After the 1st year of the study, physicians' certainty of their patients' risk factor status increased.
Certainty varied from an OR of 1.4 (95% CI: 1.1, 1.8) for prior vertebral fracture status to 6.3 (95% CI: 2.3, 17.9)
for prior hip fracture status. Furthermore, bone mineral density testing increased in high risk as compared with
low risk patients (OR: 1.4; 95% CI: 1.2, 1.7).
Conclusion: Quality Circle methodology was successful in increasing both physicians' awareness of osteoporosis
risk factors and appropriate bone mineral density testing in accordance with the 2002 Canadian guidelines.
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Background
Approximately one in four women have osteoporosis and
a 50-year old white woman has a remaining lifetime risk
of 40% for sustaining a hip, vertebra or a wrist fracture
[1,2]. These fractures have physical, psychological, social
and economic consequences that can profoundly influ-
ence health related quality of life [3-7]. With the expecta-
tion that the aging population will increase in subsequent
years [8], it is predicted that increased rates of osteoporo-
sis will also occur making it a major public health concern
worldwide. Given the millions of women who have or
will develop osteoporosis, the detection of the disease
must become as familiar to family physicians as the detec-
tion of hypertension and diabetes.
Despite the high prevalence of this disease, there is evi-
dence that patients at high risk of fracture due to oste-
oporosis are not being diagnosed or treated with
appropriate therapies [9-12]. While the Osteoporosis
Canada 2002 Canadian guidelines [9] provided evidence
based strategies in managing this condition, publication
and distribution of guidelines have not, in and of them-
selves, been shown to alter physicians' clinical approaches
[13]. Therefore, a gap exists between care delivery and best
known practices in the management of osteoporosis. The
Canadian Quality Circle (CQC) Project, a multifaceted
integrated disease management process strategy utilizing
reflective learning approaches [14,15] was developed and
implemented to reduce this care gap. We hypothesize that
primary care physicians' perceived awareness of oste-
oporosis risk factors in their patients and bone mineral
density testing would change in accordance with the Oste-
oporosis Canada guidelines as a result of their enrollment
in the study.
Methods
Physician recruitment
All participating physicians provided written informed
consent. The study was approved by Health Research Eth-
ics Boards across Canada. The study was sponsored by
research grants from the Ontario College of Family Physi-
cians and Alliance for Better Bone Health (Procter & Gam-
ble Pharmaceuticals Canada Inc. and Sanofi-Aventis
Pharma Inc.).
Facilitators
A physician-facilitator was selected for each Quality Circle
and trained to facilitate the management of the circle.
Facilitators were local family physicians recruited to lead
and initiate discussion at study meetings and were chosen
because of their skills in small group facilitation and
involvement in continuing professional development and
were selected by the study's steering committee.
Osteoporosis specialist
An osteoporosis specialist was assigned to each quality cir-
cle. The specialist was recruited on the recommendation
provided by the facilitator from the facilitator's local refer-
ral network. The role of the osteoporosis specialist was to
attend each Quality Circle meeting to provide assistance
in addressing clinical matters.
Members
Circle members were family physicians selected from spe-
cific geographical regions across Canada derived from a
list developed by the facilitator of each Quality Circle,
supplemented with physicians' names from the provincial
College of Family Physician's membership list. All poten-
tial members received a written introductory letter from
the local circle facilitator and were invited to participate in
the study. A maximum of 15 physicians in each geograph-
ical area were enrolled into each circle in the study. Family
physicians are defined as physicians who take profes-
sional responsibility for the comprehensive care of unse-
lected patients with undifferentiated problems and are
committed to the person regardless of gender, age, or ill-
ness [16].
Overview of project phases
The overall project consisted of five Quality Circle phases.
Members committed to the first year of the project, which
consist of Quality Circle phases one to three. Those who
were interested and willing to commit to the second year
of the project completed the remaining 2 project phases.
The five phases include: 1) Introduction, Training & Base-
line Data Collection, 2) First Educational Intervention &
First Follow-Up Data Collection 3) First Strategy Imple-
mentation Session, 4) Final Educational Intervention &
Final Follow-up Data Collection, and 5) Final Strategy
Implementation Session (Figure 1). Participants received
continuing professional development credits from the
College of Family Physicians of Canada (12 MAINPRO-C
credits (or 24 MAINPRO-M1 credits)) per year for partici-
pation.
This article describes the changes in physician behaviour
during the first year of the project, but the over-all time-
line of the Project is summarized in Figure 1, and the
detailed description of all 5 phases follows.
Phase 1: introduction, training & baseline data collection
Project training was conducted via baseline circle meet-
ings and involved a systematic examination of the study
protocol, and a review of the project data collection form.
Following training, each member collected baseline
patient data from their own practice using a standardized
baseline data collection form to ascertain current practice
patterns for the diagnosis and treatment of osteoporosis.
Once the data were evaluated, the Steering CommitteeBMC Musculoskeletal Disorders 2008, 9:130 http://www.biomedcentral.com/1471-2474/9/130
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Five phases of the Canadian quality circle project Figure 1
Five phases of the Canadian quality circle project. 1) Introduction, Training & Baseline Data Collection, 2) First Educa-
tional Intervention & First Follow-Up Data Collection 3) First Strategy Implementation Session, 4) Final Educational Interven-
tion & Final Follow-up Data Collection, and 5) Final Strategy Implementation Session & final follow-up data collection (Figure 
1). Members committed to the first year of the project, which consist of Quality Circle phases one to three. Those who were 
interested and willing to commit to the second year of the project completed the remaining project phases (four and five).
Training & Baseline Data Collection 
 
Train-the-Trainer Meeting (training of Facilitator) 
Training Quality Circle Meeting (3 months) 
Circle Member Baseline Data Collection (2 to 3 months) 
Total Duration: 5 to 6 months 
First Educational Intervention & First Follow-Up Data Collection 
 
Train-the-Trainer Meeting (training of Facilitator) 
Profile Generation, and Dissemination 
Educational Intervention Circle Meeting (4 months) 
Circle Member Follow-up Data Collection (2 to 3 months) 
Total Duration: 6 to 7 months 
First Strategy Implementation Session 
 
Train-the-Trainer Meeting (training of Facilitator) 
Implementation of Care Strategies Circle Meeting (2 months) 
Plans were implemented over 3 months 
Total Duration: 5 months 
Final Educational Intervention & Final Follow-up Data Collection 
 
Train-the-Trainer Meeting (training of Facilitator) 
Profile Generation, and Dissemination 
Modified Educational Intervention Circle Meeting (4 months) 
Circle Member Follow-up Data Collection (2 months) 
Total Duration: 6 month
Final Strategy Implementation Session 
 
Train-the-Trainer Meeting (training of Facilitator) 
Implementation of Care Strategies Circle Meeting (2 months) 
Close-out (Circle members, Facilitator and Specialist) 
Total Duration: 2 months BMC Musculoskeletal Disorders 2008, 9:130 http://www.biomedcentral.com/1471-2474/9/130
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met to review findings and determine key learnings that
circle members should know. Key learnings were used to
produce Physician Profiles. Profiles are "snapshots" of
members' practice patterns showing how they managed
osteoporosis including risk factor identification, bone
mineral density testing, and therapies. Physician profiles
were displayed graphically with a brief text summary. The
profiles permitted anonymous comparisons of individual
circle member data with their peers in their circle and with
all the participating physicians in the project.
Phase 2: first educational intervention & first follow-up data collection
The educational intervention was initiated through a
phase 2 Quality Circle meeting. The intervention con-
sisted of two parts, 1) the presentation and discussion of
baseline individual, group and overall Quality Circle Pro-
files. The profiles were provided to the members on-site.
Then 2) educational materials related to the 2002 Oste-
oporosis Canada guidelines were distributed, discussed
and an educational workshop was conducted. The facilita-
tors led group discussions with their circles to identify bar-
riers in managing osteoporosis as suggested by the
guidelines and strategies to improve patient care. Follow-
ing the educational intervention, a second phase of data
collection was conducted by each member on additional
patients using the follow-up Quality Circle collection
form. Following the data collection period, the Steering
Committee reviewed the findings, generated key learn-
ings, and determined the next intervention.
Phase 3: first strategy implementation session
A strategy implementation meeting was conducted com-
paring individual, group and overall Quality Circle pro-
files from the baseline and first follow-up data collection
periods. Discussions concerning the progress made by
incorporating strategies identified in the prior phases of
the project were shared among the group. Based on the
major findings from the profiles, members discussed
additional measures that should be implemented in their
practices to increase alignment with the 2002 guidelines.
Phase 4: final educational intervention & final follow-up data 
collection
The final Quality Circle educational intervention meet-
ings – phase 4 – were similarly designed to the first educa-
tional intervention meetings. However, the educational
intervention focused on areas where the data showed phy-
sicians demonstrated suboptimal knowledge regarding
the appropriate management of osteoporosis according
the 2002 guidelines. Following the second educational
intervention, data were collected by each physician on
additional patients using the Quality Circle collection
form.
Phase 5: final strategy implementation session
The final phase 5 strategy implementation meetings were
similarly designed to the first strategy implementation
meetings.
Procedures for data collection
Criteria for patient selection, screening & completion of the quality 
circle collection forms
Eligible patients met the following criteria: women 55
years of age and older, known to the physician, and
attended at least two visits to the physician's clinic in the
24 months prior to enrollment. The screening of eligible
patients was conducted by the clinic nurse to overcome
the possibility of physician bias. At the end of each recruit-
ment day, the nurse used the day's visit schedule to ran-
domly select three or four medical charts of patients that
met the study's eligibility criteria. After making the selec-
tion, the nurse placed the patient questionnaire into each
patient chart and the family physician completed the
form. Each form was one page and took approximately 5
minutes to complete. All forms were faxed to a central site
and the information was incorporated in an electronic
database for analysis. For each data collection period
(phases one, two and four), a total of 25 different patients
were randomly selected for evaluation. Over the course of
the study, the forms were slightly modified to better cap-
ture important clinical data.
Multifaceted educational intervention
The educational intervention consisted of eight key com-
ponents: 1) audit and feedback, where standardized Qual-
ity Circle Data Collection Forms were used to audit
physicians' practices and physicians profiles were gener-
ated to provide feedback; 2) interactive small group dis-
cussions at all 5 Quality Circle meetings, where
participants could safely reflect on their own practice pat-
terns compared to their peers and compared to a gold
standard; 3) use of opinion leaders who were local pri-
mary care physicians who not only served as meeting facil-
itators but as peers who thought the information being
discussed was important; 4) reminders, where the stand-
ardized collection forms, being filled out repeatedly over
a number of weeks, triggered thought on a patient's risk
factors for fracture, bone mineral density utilization, and
therapies; 5) multi-professional collaboration and com-
munity building where osteoporosis specialists attended
each Quality Circle meeting to provide assistance in
addressing clinical matters but also become personally
known by circle members; 6) financial intervention of
$10 for each completed standardized patient form; 7)
patient directed interventions where the primary care phy-
sicians distributed Osteoporosis Canada information and
educational tools for patient use; 8) and educational
workshops built on needs assessments of the participants
as defined by the data collected from participants ownBMC Musculoskeletal Disorders 2008, 9:130 http://www.biomedcentral.com/1471-2474/9/130
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practices and focus group feedback from a cross-section of
circle members. These interventions have been shown to
be effective in changing behaviour [17-21].
A series of five Quality Circle Educational Intervention
Workshops were developed by the Core Educational
Committee consisting of members of the Osteoporosis
Canada, Ontario College of Family physicians, leading
physicians and scientists, and industry partners. The 2002
Osteoporosis Canada guidelines were used as the main
evidence-based reference for the workshops. The work-
shops were developed to meet the identified needs of the
cohort and required 60–90 minutes to administer during
the circle meetings.
Risk factor assessment and bone densitometry
According to the Osteoporosis Canada 2002 guidelines,
all postmenopausal women over the age of 50 years
should be assessed for the presence of risk factors for oste-
oporosis. A patient was considered to be at high risk if
they had one major or 2 or more minor risk factors for
fracture. Low risk patients had at most one minor risk fac-
tor for fracture [9].
For individuals under the age of 65 years, a bone mineral
density measurement is recommended for those who
have at least one major, or 2 minor risk factors for future
fracture (high risk). In addition, all women 65 years of age
and older should have a bone mineral density test con-
ducted because of the high risk of osteoporosis and frac-
ture in this group [9].
Statistical analysis
The generalized estimating equations [22] approach was
used to model differences in physician perceived certainty
of risk factors for osteoporosis and appropriate utilization
of bone mineral density testing pre and post educational
intervention (first year of the study). An exchangeable cor-
relation matrix was used for the analyses. Physicians'
awareness of the following risk factors were examined: age
65 years and older; prior fragility fracture after age 40
years at the hip wrist, or spine; family history of fracture;
menopause before age 45 years; any other major risk fac-
tor; and two or more minor risk factors. Generalized esti-
mating equations method was used to take into account
the clustered nature of the data; given that patients treated
within a primary care physician should be correlated
(clustered variable is the physician). For the model, the
unit of analysis is the patient and the unit of inference is
the physician. Separate models were conducted for the
dependent variables, risk factor certainty and appropriate
bone mineral density testing. Unadjusted and adjusted
odds ratios (OR) and corresponding 95% confidence
intervals (CI) are reported.
A physician was certain about a patient's particular risk
factor if the physician indicate on the standardized form
that the patient had (yes) or did not have (no) the risk fac-
tor. If the physician was unsure, the physician indicated
uncertain on the standardized form. Appropriate bone
mineral density testing was defined, based on the Oste-
oporosis Canada guidelines, as testing in those who have
at least one major, or 2 minor risk factors for future frac-
ture (high risk) or not testing in patients with one minor
or no risk factors. Given that only those who were inter-
ested and willing to commit to the second year of the
project completed year two of the study, the analyses were
conducted for only the first year. Goodness-of-fit of each
model was assessed using the method developed by Hor-
ton et al. [23].
All statistical analyses were performed using the SAS/STAT
(version 9.1; SAS Institute Inc., Cary, North Carolina,
USA) software package running on Windows XP Profes-
sional. The criterion for statistical significance was set at α
0.05.
Results
A total of 340 family physician circle members formed 34
quality circles and participated in the study. During the
first year of the study, 39 physicians (11.5%) dropped out
of the study (Table 1). Quality circles were developed in
seven provinces including 5 in British Columbia, 3 in
Alberta, 1 in Saskatchewan, 11 in Ontario, 11 in Quebec,
1 in New Brunswick, 1 in Nova Scotia. Bone mineral den-
sity testing was conducted in 66% (5549/8371) and 74%
(5431/7328) of the patient population at baseline and the
first follow-up, respectively.
Awareness of risk factors
The percentage of primary care physicians who were
uncertain of their patients' risk factor status was generally
low. However, at baseline, approximately 50% (4238/
8368), 22% (1794/8364) and 10% (823/8365) of physi-
cians professed uncertainty about three key historical
facts: their patients' family history of fracture, early meno-
pausal status, and prior vertebral fracture history, respec-
tively (Table 2). Results generated from the generalized
estimating equations method showed that physicians' cer-
tainty of risk factor awareness significantly increased dur-
ing the first year of the study. This implies that more
physicians indicated that they were aware of the patients'
risk factor status (either the patient had or did not have
the risk factor) then were unaware during the course of the
study. Improvement varied from an OR of 1.4 (CI: 1.1,
1.8) for prior vertebral fracture status to 6.5 (CI: 2.4, 17.5)
for prior hip fracture status (Figure 2).BMC Musculoskeletal Disorders 2008, 9:130 http://www.biomedcentral.com/1471-2474/9/130
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Appropriate bone mineral density testing
At baseline, 68.3% (4426/6482) of high risk patients were
administered a bone mineral density test as compared
with 59.5% (1123/1889) of low risk patients. During the
first follow-up, 78.2% (4343/5557) of high risk patients
were administered a bone density test as compare with
61.4% (1088/1771) of low risk patients (Table 3). Appro-
priate bone mineral density testing significantly improved
at the end of the 1st year of the study as indicated by the
unadjusted and adjusted OR and 95% CI (Figure 3). How-
ever, there are many reasons why physicians administered
or did not administer bone density tests in high and low
risk patients (Tables 4).
Discussion
Given the magnitude of the community health problem
associated with osteoporosis, managing the disease must
shift from specialists to family physicians. Family physi-
cians are a trusted source of health information to their
patients and have a unique opportunity to proactively
Table 1: Study and patient characteristics of the quality circle project
Baseline 1st Follow-up
Study characteristics: n
Number of provinces 7 7
Number of cities 109 97
Number of circles 34 34
Number of physicians 340 301
Number of chart reviews 8376 7354
Risk factors for fracture: n with characteristic/total n (%)
Age ≥ 65 yrs 5337/8362 (63.8) 4440/7341 (60.5)
Prior hip fracture 152/8366 (1.8) 187/7344 (2.6)
Prior wrist fracture 353/8367 (4.2) 393/7345 (5.3)
Prior vertebral fracture 486/8365 (5.8) 481/7339 (6.6)
Family history of fracture 431/8368 (5.2) 649/7337 (8.9)
At least 1 fall in the previous 12 months 926/8365 (11.1) NA*
Oral Prednisone therapy (> 3 months) 353/8366 (4.2) NA*
Menopause before age 45 yrs 689/8364 (8.2) 643/7339 (8.8)
Any other major risk factor 3485/8364 (41.7) 1166/7329 (25.1)
Two or more minor risk factors 1467/8356 (17.6) 1378/7326 (18.8)
High risk 6486/8376 (77.4) 5569/7354 (75.7)
Bone density testing: n with characteristic (%) n = 8371 n = 7328
No test 2822 (33.7) 1897 (25.9)
T-score: >-1 1490 (17.5) 1295 (17.7)
T-score: -1 to -2.5 2028 (24.2) 2282 (31.4)
T-score: <-2.5 1774 (21.2) 1272 (17.4)
Test results pending 257 (3.1) 582 (7.9)
*NA = not available (it was not measured during follow-up).
Table 2: Physicians' perceived uncertainty of their patients risk factor status
Patient characteristics: n uncertain/total n (%) Baseline 1st Follow-up n (%)
Age ≥ 65 yrs 0/8362 (0.0) 1/7341(< 0.1)
Prior hip fracture 151/8366 (1.8) 23/7344 (0.3)
Prior wrist fracture 238/8367 (2.8) 93/7345 (1.3)
Prior vertebral fracture 823/8365 (9.8) 537/7339 (7.3)
Family history of fracture 4238/8368 (50.7) 1939/7337 (26.4)
At least 1 fall in the previous 12 months 853/8365 (10.2) NA*
Oral Prednisone therapy (> 3 months) 92/8366 (1.1) NA*
Menopause before age 45 yrs 1794/8364 (21.5) 835/7339 (11.4)
Any other major risk factor 176/8364 (2.1) 63/7329 (0.9)
Two or more minor risk factors 518/8356 (6.2) 131/7326 (1.8)
Physician's check off the uncertain option on the standardized form for the above patient characteristics (physicians were unaware whether their 
patients had this characteristic). *NA = not available (it was not measured during follow-up).BMC Musculoskeletal Disorders 2008, 9:130 http://www.biomedcentral.com/1471-2474/9/130
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Change in physicians' perceived certainty of their patients' risk factor status during the 1st year of the study Figure 2
Change in physicians' perceived certainty of their patients' risk factor status during the 1st year of the study. 
The generalized estimating equations approach was used to model differences in physician perceived awareness of risk factors 
pre and post 1st educational intervention. Values are expressed as adjusted and unadjusted odds ratios (OR) and corresponding 
95% confidence intervals (CI) are reported. Generalized estimating equations method was used to take into account the clus-
tered nature of the data (patients within physicians). All risk factors in figure 2 were included in the adjusted analysis. Overall 
Certainty = all the risk factors in figure 2 combined. UP = upper. The fit of the models ranged from 0.714 to < 0.001.
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prevent and treat osteoporosis in their practice for the rea-
son that in most patient/primary care physicians relation-
ships there are many opportunities for the physician to
assess osteoporosis.
Despite the consequences of osteoporosis, the manage-
ment of the disease is less than optimal [10-12,24]. For
instance, Juby and De Geus-Wenceslau evaluated the pres-
ence of osteoporosis from a retrospective chart review of
311 consecutive patients over 65 years of age who were
admitted to a tertiary care hospital with a diagnosis of hip
fracture. In addition, chart review was conducted on 226
patients after discharge from post-surgery rehabilitation
[12]. The results showed that osteoporosis was diagnosed
in the tertiary care hospital on admission in 11.9% and on
discharge in 15.4%. In the rehabilitation hospital, it was
diagnosed in 9.7% on admission and 11.2% on discharge
[12].
Given this care gap, our study was designed to improve
patient care. The Quality Circle technique has been previ-
ously examined in osteoporotic patients with positive
treatment outcomes. However, these circles consisted of
interdisciplinary groups of physicians [25,26]. Our study
demonstrated that Quality Circle methodology is an effec-
tive approach that improves family physicians' diagnosis
of osteoporosis. The results showed that family physicians
were more aware of their patients' risk factor status. This
indicates that physicians asked more questions regarding
a patient's risk factor status for osteoporosis during clini-
cal visits. Moreover, a higher number of high risk patients
received bone density testing as compared with low risk
patients. However, bone density testing in low risk
patients did not change dramatically following the educa-
tional intervention and the amount of testing was higher
than expected. The primary reason for this finding was
that family physicians wanted to formally assess the frac-
ture risk of these patients. Fortunately, it appeared that
these formal risk assessments were done prudently, given
the fact that approximately two thirds of low risk patients
were never administered a bone density test or were given
their most recent scan three or more years following their
last test. Results also suggested that following the Quality
Circle meetings, there was a decrease in the difference in
bone density testing in patients with a prior fracture as
compared with those without a fracture. One reason for
Table 3: Bone mineral density testing in high and low risk patients
Patient characteristics: n with characteristic/total n (%) Baseline Follow-up
Reason for being in high risk group
Facture* 706/883 (80.0) 735/922 (79.6)
Age (yr)* 3564/5333 (66.8) 3384/4433 (76.3)
Family History* 362/431 (84.0) 574/648 (88.6)
Other Major* 2389/3484 (68.6) 953/1159 (82.2)
Overall High Risk Group 4426/6482 (68.3) 4343/5557 (78.2)
Low risk group:
One minor or no risk factors 1123/1889 (59.5) 1088/1771 (61.4)
* Patients may have had other risk factors.
Table 4: Reasons why primary care physicians conducted a bone mineral density test in high and low risk patients
Group: High Risk* Group: Low Risk*
Conducted a Bone Density Test
Total # in group n = 4190 n = 1054
Patients request: # (%) 173 (4.1) 218 (20.7)
High risk due to fracture: # (%) 468 (11.2) 3 (0.3)
High risk (other): # (%) 1358 (32.4) 38 (3.6)
To asses risk for fracture: # (%) 2033 (48.5) 699 (66.3)
Other 158 (3.8) 96 (9.1)
Did not Conducted a Bone Density Test
Total # in group n = 1139 n = 646
Test not available: # (%) 17 (1.5) 1 (0.2)
Patient at low risk: # (%) 231 (20.3) 499 (77.2)
Patient refused: # (%) 188 (16.5) 15 (2.3)
Other: # (%) 703 (61.7) 131 (20.3)
* High risk: one major or two minor risk factors for fracture; Low- risk: one minor or no risk factors for fracture. These data were collected during 
Phase II.BMC Musculoskeletal Disorders 2008, 9:130 http://www.biomedcentral.com/1471-2474/9/130
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this outcome may be that physicians believed that bone
density testing was not necessary in patients with fracture
and that these patients should be administered therapy
regardless of their bone density t-score [27,28].
Although the perceived prevalence of fracture was high,
population based studies have suggest a higher prevalence
then reported in the current study particularly at the spine
[29-31]. This would suggest vertebral fractures are under-
Change in bone mineral density testing depending of risk factor status during the 1st year of the study Figure 3
Change in bone mineral density testing depending of risk factor status during the 1st year of the study. The gen-
eralized estimating equations approach was used to model differences in appropriate utilization of bone mineral density testing 
pre and post 1st educational intervention. Values are expressed as adjusted and unadjusted odds ratios (OR) and corresponding 
95% confidence intervals (CI) are reported. Generalized estimating equations method was used to take into account the clus-
tered nature of the data (patients within physicians). All risk factors in figure 3 were included in the adjusted analysis along with 
the two way interaction terms with phase. The fit of the models was < 0.001.
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reported and that strategies should be developed to
improve reporting.
The strengths of the study are numerous and include the
large number of family physicians that participated from
across Canada; thus improving the generalizability of the
results. In addition, the findings of our study were derived
from self-audits and did not rely on physicians self-
reports, which may reflect attitudes about their practice
rather than true practice. Furthermore, the audits con-
sisted of a random selection of patients from the physi-
cians' practices. Because single-component interventions
have not been shown to change clinical practice [17-19],
Quality Circle methodology combined various tech-
niques into one multifaceted intervention, which is likely
more effective at changing physician awareness and
behaviour [20,21]. This technique involved practice
audits, feedback on performance by peers, an interactive
discussion of evidence, small group physician education
workshops that were led by local primary care physicians
and supported by osteoporosis specialists, diagnosis and
treatment reminders, and making personal learning plans
for improving clinical management of osteoporosis in
accordance with the OC 2002 guidelines. Finally the
Quality Circle technique, consisted of short duration
meetings with little financial incentives, thus the feasibil-
ity of using this approach in osteoporosis aware physi-
cians in other settings is high.
Nonetheless, our study is not without limitations.
Patients evaluated in the study were postmenopausal
women and as a consequence, our results may not be
applicable to men, or premenopausal women. Given that
recruitment was based on a physician's interest in oste-
oporosis and women's health, these clinicians may have
greater experience and comfort in managing the disease
from the onset. In addition, this recruitment strategy may
result in some selection bias, which may have influenced
our findings.
Furthermore, the physicians that participated in the study
were from urban settings and it has been shown that
urban physicians may order more bone density tests as
compared with rural physicians [32]. Moreover, a rand-
omized control trial of physicians will be needed to con-
firm the current study's results. Finally, it is important to
consider that clinical practice guidelines are intended to
provide physicians with the current best evidence from
clinical research to help them make health care decisions
regarding osteoporosis; however, clinical judgment and
the patient's preference, will determine if, when and what
treatment is initiated. As a result, 100% adherence to the
guidelines is not warranted.
Conclusion
In conclusion, because osteoporosis is a multifactorial
condition, its prevention and management are complex. It
is important that physicians recognize the risks for oste-
oporosis and fracture and that these factors should be
used to identify individuals who may benefit from bone
density testing. The Quality Circle technique is an effective
stepwise knowledge translation approach that increases
primary care physicians' awareness and assessment of
osteoporosis in accordance with the Osteoporosis Canada
2002 guidelines.
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